SCHEMBL19976846

SCHEMBL19976846

CC(C)CN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HDAC6 Q9UBN7 1/20 0.39
DYRK1A Q13627 5/20 0.39
ABL1 P00519 1/20 0.38
BCR P11274 1/20 0.38
MAPK10 P53779 4/20 0.38
MAPK8 P45983 3/20 0.38
MAPK1 P28482 4/20 0.37
GSK3B P49841 3/20 0.37
PAK4 O96013 2/20 0.37
PLK4 O00444 1/20 0.37
MAPK13 O15264 1/20 0.37
DAPK3 O43293 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
CDK1 P06493 1/20 0.37
PIM1 P11309 1/20 0.37
CDK2 P24941 1/20 0.37
MARK3 P27448 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976866 0.90 DYRK1A (0.42) DYRK1AMAPK8MAPK1GSK3BPAK4
SCHEMBL19976776 0.89 GSK3B (0.48) HDAC6DYRK1AMAPK1GSK3B
SCHEMBL19976857 0.88 MAPK1 (0.35) KDM4EHDAC6DYRK1AABL1BCR
SCHEMBL19976766 0.88 ABL1 (0.43) KDM4EALDH1A1HDAC6DYRK1AABL1
SCHEMBL19976757 0.87 HDAC6 (0.39) HDAC6DYRK1AABL1BCRMAPK10
SCHEMBL19976767 0.87 GSK3B (0.51) HDAC6MAPK10MAPK8MAPK1GSK3B
SCHEMBL19976854 0.87 GSK3B (0.42) HDAC6DYRK1AMAPK10MAPK8MAPK1
SCHEMBL19976926 0.86 GRM4 (0.48) DYRK1A
SCHEMBL19976789 0.86 GSK3B (0.42) HDAC6DYRK1AMAPK1GSK3BCDK1
SCHEMBL19976781 0.84 TRPA1 (0.35) KDM4EDYRK1AABL1BCRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed